MIMETIBODY

pharmaceutical composition, namely, small peptide or protein fused with an antibody or antibody fragment for use in the treatment of cancer, renal failure, anemia, cardiovascular disease, metabolic disease, immune and inflammatory diseases, and infectious diseases